This article looks at how the cascade of care for tuberculosis infection screening and treatment have been implemented in primary care settings globally.

A report on the experiences of Australian general practitioners in 2020 and 2021 during the COVID-19 pandemic.

An overview of prostate cancer patient support programs in Australia to help general practitioners direct patient referrals and optimise clinical care.

This article describes the co-design, implementation and use of documentation shortcuts for chlamydia management.

The unregulated implementation of risk algorithms in tools might miss identifying patients at high risk of cardiovascular disease.

This issue explores ‘old’ infectious diseases (scabies, syphilis), ‘new’ infectious diseases (CJD, COVID-19), and medical advances such as RSV prevention products and point-of-care testing.

Expanding the publications from the prior issue, we explore key aspects of melanoma diagnosis and management, and modern approaches to radiotherapy.

This study considers the causes and magnitude of melanoma overdiagnosis in Australia, and speculates about a possible benefit of overdiagnosis in Australia.

This review summarises the evolving status of melanoma care, emphasising when to refer patients to medical oncologists as part of the multidisciplinary team.

This review examines the efficacy, advances and treatment considerations of radiation therapy for the management of keratinocyte cancer, and role of the GP.

This article discusses advances in imaging and early diagnosis including the use of artificial intelligence in this process.

Acute onset of facial eruption could be caused by infectious or non-infectious aetiologies.

The purpose of this study was to develop a clinical prediction rule based on identified risk factors for surgical site infection in a large general practice patient cohort.

Large-diameter lentigo maligna on sites of functional and cosmetic importance presents a difficult management issue.

Clinicians should be alert to factors contributing to increased non-melanoma skin cancers.